Therese Bittermann, MD, MSCE

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Education:
BA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

I care for patients with viral hepatitis, auto-immune diseases of the liver, fatty liver disease, liver tumors, and cirrhosis. I also have expertise in pre- and post-transplantation management.

Description of Research Expertise

I study the relationship between immunosuppression strategy and outcomes after liver transplantation. I have previous expertise in research related to organ allocation, the effects of transplant policymaking and center variability in patient care. I have an advanced degree in clinical epidemiology, and have expertise with observational study designs, large databases and statistics.

Selected Publications

Sasha Deutsch-Link, Ethan M Weinberg, Therese Bitterman, Mackenzie McDougal, Aniket Dhariwal, Lauren S Jones, Robert M Weinrieb, Arpita G Banerjee, Senayish Addis, Marina Serper : The Stanford Integrated Psychosocial Assessment for Transplant is Associated with Outcomes Before and After Liver Transplantation Liver Transplantation Dec 2020.

Bittermann T, Reddy KR: In the era of direct-acting antivirals, liver transplant delisting due to clinical improvement for hepatitis C remains infrequent. Clinical Gastroenterology and Hepatology Epub ahead of print, September 2020.

Wong NZ, Schaubel DE, Reddy KR, Bittermann T : Transplant center experience influences spontaneous survival and waitlist mortality in acute liver failure: an analysis of the UNOS database American Journal of Transplantation Epub ahead of print, August 2020.

Durkin C, Kaplan DE, Bittermann T: T2 Hepatocellular Carcinoma Exception Policies That Prolong Waiting Time Improve the Use of Evidence-based Treatment Practices. Transplantation Direct Epub ahead of print, August 2020.

Mezochow AK, Abt PL, Bittermann T.: Differences in early immunosuppressive therapy among liver retransplantation recipients in a national cohort. Transplantation Epub ahead of print, August 2020.

Bittermann T, Dwinnells K, Chadha S, Wolf MS, Olthoff KM, Serper M : Low health literacy is associated with frailty and reduced likelihood of liver transplant listing: a prospective cohort study Liver Transplantation June 2020.

Bittermann T, Hubbard R, Lewis JD, Goldberg DS: The proportion of Model for End-stage Liver Disease Sodium score attributable to creatinine independently predicts post-transplant survival and renal complications. Clinical Transplantation Epub ahead of print, March 2020.

Deutsch-Link S, Weinberg EW, Bittermann T, Serper M: Letter Response to: Using Medication Level Variability to Predict Post-Transplant Risk Liver Transplantation Epub ahead of print, 2020.

Deutsch-Link S, Weinberg EW, Bittermann T, McDougal M, Dhariwal A, Jones LS, Robert M Weinrieb, Banerjee AG, Addis S, Serper S : The Stanford Integrated Psychosocial Assessment for Transplant is Associated with Outcomes Before and After Liver Transplantation Liver Transplantation Epub ahead of print, 2020.

Bittermann T, Hubbard RA, Lewis JD, Goldberg DS: The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes. American Journal of Transplantation Dec 2019.

back to top
Last updated: 02/17/2021
The Trustees of the University of Pennsylvania